Lack of alternative treatments for epiphora medical disorders is a key restraint on the Nasal Lacrimal Stent Market

A nasolacrimal stent is a tiny tube that is used to treat disorders such as epiphora, as well as dacryocystorhinostomy (DCR) and congenital nasolacrimal blockage. The market for nasal lacrimal stents is predicted to develop as the prevalence of nasolacrimal duct blockage (NLDO), a prevalent lacrimal system condition, rises. For example, according to data published in 2019, by the NCBI (National Center for Biotechnology Information), the prevalence of nasolacrimal duct obstruction has been found around 6% to 20% in global infants.



 Drivers of Nasal Lacrimal Stent Market

Because of continuous research on products to treat Epiphora and Dacryocystorhinostomy disease situations, the nasal lacrimal stent market is likely to grow throughout the forecast period. For example, Alon Kahana of the University of Michigan sponsored a study in October 2019 to assess the safety and efficacy of the slit stent ii lacrimal stents for the treatment of nasolacrimal duct obstruction.

In addition, the availability of improved products is projected to propel this industry forward. Nunchaku and BIKA intubation systems, a bicanalicular stent used to drain tears by capillary, are among the devices offered by FCI Ophthalmics.

Nasal Lacrimal Stent Market- Restraints

The lack of alternative treatments for epiphora medical disorders is a key restraint on the market for nasal lacrimal stents. The majority of pharmaceutical companies are concentrating their efforts on creating new medications for the treatment of ocular illnesses.

Regional Analysis of the Nasal Lacrimal Stent Market

The nasal lacrimal stent market is divided into five regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. During the projected period, North America is expected to have a prominent position in the nasal lacrimal stent market, as key market players focus on growing their presence in the area..For example, in January 2019, FCI Ophthalmics and Carl Zeiss Canada Ltd. agreed to distribute FCI Ophthalmics' lacrimal stents and tubes in Canada, including Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (bicanicular stent), and Bika & Nunchaku (bicanicular stent).

Nasal Lacrimal Stent Market- Competitive Landscape

FCI Ophthalmics, Kaneka Corporation, Cook Medical LLC., and Sinopsys Surgical, Inc. are some of the major participants in the nasal lacrimal stent industry.

Comments

Post a Comment

Popular posts from this blog

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because
Read more

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc
Read more

From 2016-2021, Automated Fare Collection System Market predicted to rise significantly

Image
  AFC is commonly used to replace paper-based public transportation tickets with electronic tickets. The AFC system is a stored value-based, contactless smart card application that may be upgraded with the mobile ticketing application. It is meant for public transportation and micro-payment activities.AFC is commonly used to collect consumption data quickly and effectively by automatically logging transactions, allowing for better service planning and optimization, variable pricing schemes, easy access to bundled services, and consumer convenience. AFC guards against the unauthorized creation and alteration of data stored on cards. It prevents you from reading one card while writing on another. It guards against card cloning.. During the projection period, the overall Automated Fare Collection System Market is expected to increase from USD 6.42 billion in 2016 to USD 11.95 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 13.2 percent. Some of the elements that are predict
Read more